Kiniksa Pharmaceuticals International Plc (KNSA)
75.72
+0.50
(+0.66%)
USD |
NASDAQ |
Oct 02, 16:00
75.72
0.00 (0.00%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Price : 75.72 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 01, 2026 | 73.87 | 76.11 | 73.14 | 75.22 | 878563.0 |
| Sep 30, 2026 | 76.55 | 76.55 | 73.76 | 74.61 | 650611.0 |
| Sep 29, 2026 | 75.32 | 76.52 | 74.33 | 75.73 | 620703.0 |
| Sep 28, 2026 | 75.00 | 76.42 | 74.02 | 76.10 | 734142.0 |
| Sep 25, 2026 | 75.40 | 76.00 | 74.53 | 75.08 | 478994.0 |
| Sep 24, 2026 | 76.02 | 76.95 | 74.46 | 75.34 | 433364.0 |
| Sep 23, 2026 | 77.99 | 78.23 | 74.88 | 76.08 | 408456.0 |
| Sep 22, 2026 | 78.09 | 79.54 | 77.37 | 78.00 | 403996.0 |
| Sep 21, 2026 | 77.12 | 78.73 | 75.90 | 78.13 | 482846.0 |
| Sep 18, 2026 | 78.95 | 79.61 | 76.99 | 77.24 | 1.058M |
| Sep 17, 2026 | 78.66 | 79.76 | 78.29 | 79.33 | 722009.0 |
| Sep 16, 2026 | 75.06 | 77.64 | 74.91 | 77.62 | 553900.0 |
| Sep 15, 2026 | 76.46 | 76.63 | 74.47 | 75.15 | 488920.0 |
| Sep 14, 2026 | 77.89 | 77.89 | 75.02 | 76.58 | 646081.0 |
| Sep 11, 2026 | 77.70 | 78.59 | 76.14 | 76.27 | 576561.0 |
| Sep 10, 2026 | 77.66 | 78.42 | 75.99 | 76.48 | 459836.0 |
| Sep 09, 2026 | 78.72 | 80.22 | 77.33 | 78.52 | 588383.0 |
| Sep 08, 2026 | 76.25 | 78.50 | 75.00 | 77.09 | 677304.0 |
| Sep 04, 2026 | 79.75 | 80.43 | 77.90 | 77.91 | 430045.0 |
| Sep 03, 2026 | 80.30 | 81.41 | 78.84 | 80.47 | 634927.0 |
| Sep 02, 2026 | 79.53 | 80.18 | 77.86 | 79.89 | 568482.0 |
| Sep 01, 2026 | 78.29 | 79.55 | 77.86 | 79.28 | 387221.0 |
| Aug 31, 2026 | 78.00 | 78.96 | 76.65 | 78.63 | 428069.0 |
| Aug 28, 2026 | 79.60 | 79.81 | 77.71 | 78.08 | 427301.0 |
| Aug 27, 2026 | 78.20 | 80.79 | 77.80 | 79.80 | 413275.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Autolus Therapeutics Plc | 1.775 |
| Scancell Holdings Plc | 0.141 |
| OptiBiotix Health Plc | 0.11 |
| Adaptimmune Therapeutics Plc | 0.038 |
| Oxford Biomedica Plc | 6.65 |
Price Related Metrics
| PE Ratio | 76.99 |
| PS Ratio | 7.371 |
| PEG Ratio | 0.0335 |
| Price to Book Value | 9.026 |
| Price to Free Cash Flow | 33.90 |
| Earnings Yield | 1.30% |
| Market Cap | 5.905B |
| PEGY Ratio | 0.0335 |
| Operating PE Ratio | 61.82 |
| Normalized PE Ratio | 76.99 |